BEGONIA trial: durvalumab plus trastuzumab deruxtecan for HER2-low metastatic breast cancer
In one of oncology's most closely watched experiments, an antibody-drug conjugate paired with an immune checkpoint inhibitor has produced unusually ...
Tag: immune checkpoint inhibitors in breast cancer
Carboplatin ± Nivolumab in Metastatic TNBC Trial
In a groundbreaking advancement that could reshape the therapeutic landscape for metastatic triple-negative breast cancer (mTNBC), researchers have conducted a ...
Talimogene and Atezolizumab Trial in HER2-Negative Breast Cancer
In a remarkable stride toward advancing cancer immunotherapy, a recent phase II clinical trial has illuminated the promising synergy between ...
New Study Reveals How Targeting Macrophage “Bodyguard” Cells May Overcome Endocrine Resistance in Breast Cancer Treatment
In the relentless quest to conquer breast cancer, researchers at the Sylvester Comprehensive Cancer Center, part of the University of ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!